Would you consider caplacizumab in a pregnant patient with iTTP?
1 Answers
Mednet Member
Medical Oncology · Duke University School of Medicine
As noted, caplacizumab was not studied in pregnancy (was an exclusion criteria) and is not approved in this setting.
With that being said, as noted, caplacizumab use in pregnancy has been described in case reports (1, 2, 3) and in the post-partum setting (4). I would consider the use of caplacizumab ...